MAPT and Alzheimer disease: Given the high concordance between plasma p-tau217 with neuropathological, CSF, and Aβ and tau PET biomarkers of AD, the objective of this study was to investigate the relationship between p-tau217 and AD-related cognitive markers such as frPSI and SIEs on the LASSI-L.